Supportive Care in Cancer

, Volume 18, Issue 9, pp 1235–1236

Erratum to: Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies

  • Mariko Wada
  • Satoru Nagata
  • Masahiro Saito
  • Toshiaki Shimizu
  • Yuichiro Yamashiro
  • Takahiro Matsuki
  • Takashi Asahara
  • Koji Nomoto
Erratum

DOI: 10.1007/s00520-010-0938-2

Cite this article as:
Wada, M., Nagata, S., Saito, M. et al. Support Care Cancer (2010) 18: 1235. doi:10.1007/s00520-010-0938-2
  • 501 Downloads

Erratum to: Support Care Cancer

DOI 10.1007/s00520-009-0711-6

Unfortunately, an error occured in Table 3 of the article. Please find below the corrected table.
Table 3

Fecal microflora after the administration of the study products

 

Weeks after the beginning of intervention

 

0 W

2 W

3 W

4 W

5 W

6 W

 

Placebo

B. breve

Placebo

B. breve

Placebo

B. breve

Placebo

B. breve

Placebo

B. breve

Placebo

B. breve

Anaerobes

            

 Total anaerobes

9.8 ± 0.7 (4/4)

10.1 ± 0.8 (11/11)

9.6 ± 0.6 (7/7)

10.2 ± 0.4 (9/9)

9.7 ± 0.3 (8/8)

10.1 ± 0.5 (7/7)

9.9 ± 0.5 (13/13)

9.9 ± 0.9 (13/13)

9.6 ± 0.9 (7/7)

9.9 ± 0.9 (9/9)

9.8 ± 0.5 (7/9)

10.5 ± 0.1 (2/2)

 Clostridium leptum subgroup

8.9 ± 0.7 (4/5)

9.2 ± 1.1 (13/13)

8.1 ± 0.8 (9/9)

9.4 ± 0.5* (9/9)

8.8 ± 0.6 (9/10)

8.1 ± 1.3 (9/10)

9.0 ± 0.7 (13/14)

9.0 ± 0.9 (12/13)

8.7 ± 1.4 (9/10)

9.0 ± 1.3 (7/9)

8.7 ± 0.9 (9/11)

9.5 ± 0.5 (6/6)

 B. stain Yakult

ND (0/4)

ND (0/11)

ND (0/7)

6.1 ± 2.3 c (6/9)

ND (0/10)

6.6 ± 1.0 c (7/7)

ND (0/13)

5.9 ± 1.3 c (12/13)

ND (0/7)

6.8 ± 2.0 c (8/8)

ND (0/9)

8.0 c (1/2)

Facultative anaerobes

            

 Total facultative anaerobes

8.4 ± 0.9 (4/4)

8.5 ± 0.8 (11/11)

9.2 ± 0.8 (7/7)

8.0 ± 1.0 (9/9)

8.8 ± 1.1 (10/10)

9.1 ± 0.8 (7/7)

8.8 ± 1.0 (13/13)

8.5 ± 0.8 (13/13)

8.6 ± 1.3 (7/7)

8.4 ± 0.9 (9/9)

8.7 ± 1.0 (9/9)

8.3 (2/2)

 Enterobacteriaceae

5.6 ± 0.8 (2/4)

6.1 ± 2.5 (10/11)

6.6 ± 1.2 (7/7)

5.7 ± 2.8 (5/7)

7.9 ± 1.7 b (8/10)

7.5 ± 0.9 (6/7)

6.6 ± 2.4 b (10/13)

6.6 ± 2.0 (8/13)

5.8 ± 2.7 (4/7)

7.0 ± 1.9 (7/9)

6.5 ± 2.3 (6/9)

9.0 (1/2)

 Enterococcus

7.4 ± 1.3 (4/4)

8.2 ± 1.5 (11/11)

9.1 ± 1.0 (7/7)

7.5 ± 0.9 a (9/9)

8.6 ± 1.1 (10/10)

8.7 ± 1.2 (7/7)

8.6 ± 1.3 (13/13)

8.2 ± 1.1 (13/13)

8.2 ± 1.6 (7/7)

8.2 ± 1.2 (9/9)

8.7 ± 1.7 (9/9)

8.2 (2/2)

Aerobes

            

 Bacillus

5.7 ± 2.0 (3/4)

5.1 ± 1.7 (10/11)

3.2 (1/7)

4.9 ± 1.6 (7/9)

5.3 ± 2.4 (7/10)

5.1 ± 2.0 (5/7)

4.4 ± 1.4 (8/13)

5.8 ± 2.2 (8/13)

5.3 ± 2.0 (5/7)

4.5 ± 1.7 b (7/9)

5.1 ± 1.7 (7/9)

2.9 (2/2)

 Pseudomonas

ND (0/4)

ND (0/11)

ND (0/7)

ND (0/9)

ND (0/10)

ND (1/7)

ND (0/13)

4.0 (1/13)

ND (0/7)

ND (0/9)

ND (0/9)

ND (0/2)

Values are mean ± SD (Real-time PCR, log10 cells/g of feces: Culture technique, log10 CFU/g of feces)

ND, Not detected (Real-time PCR, <6.0 log10 cells/g of feces: Culture technique, <1.6 - <2.9 log10 CFU/g of feces)

(), Incidence (number of patients detected/number of patients measured)

Statistical Software: SPSS Ver. 11 (SPSS Japan Inc.), 2-sidid p-value < 0.05

Unpaired-t test:*p < 0.05, ** p < 0.01

Paired-t test: 0 W vs 2 W;a p < 0.05, 2Wvs 3,4,5 or 6 W; b p < 0.05, bb p < 0.01

Fisher’s exact test: c p < 0.01

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Mariko Wada
    • 1
    • 2
  • Satoru Nagata
    • 1
    • 2
  • Masahiro Saito
    • 2
  • Toshiaki Shimizu
    • 2
  • Yuichiro Yamashiro
    • 1
  • Takahiro Matsuki
    • 3
  • Takashi Asahara
    • 3
  • Koji Nomoto
    • 1
    • 3
  1. 1.Department of Laboratory for Probiotics ResearchJuntendo University School of MedicineTokyoJapan
  2. 2.Department of PediatricsJuntendo University School of MedicineTokyoJapan
  3. 3.Yakult Central Institute for Microbiological ResearchTokyoJapan